Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy

dc.contributor.author	Fernández Álvarez, Ramón
dc.contributor.author	González Rodríguez, Ana Pilar
dc.contributor.author	Domínguez Iglesias, Francisco
dc.date.accessioned	2016-04-12T12:40:48Z
dc.date.available	2016-04-12T12:40:48Z
dc.date.issued	2015
dc.identifier.citation	Leukemia and Lymphoma, 56(11), p. 3096-3102 (2015); doi:10.3109/10428194.2015.1038709
dc.identifier.issn	1042-8194
dc.identifier.uri	http://hdl.handle.net/10651/36449
dc.description.statementofresponsibility	(et al.)
dc.format.extent	p. 3096-3102
dc.language.iso	eng
dc.relation.ispartof	Leukemia and Lymphoma
dc.rights	©,
dc.source	Scopus
dc.source.uri	http://www.scopus.com/inward/record.url?eid=2-s2.0-84947815423&partnerID=40&md5=f43b07f22a042c2447ce45de572031ff
dc.title	Serum ferritin as prognostic marker in classical Hodgkin lymphoma treated with ABVD-based therapy
dc.type	journal article
dc.identifier.doi	10.3109/10428194.2015.1038709
dc.relation.publisherversion	http://dx.doi.org/10.3109/10428194.2015.1038709

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.